Viking Therapeutics (VKTX) Interest Coverage Ratio Growth (5y) (2019 - 2026)
Viking Therapeutics (VKTX) Interest Coverage Ratio Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Viking Therapeutics | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.44% |
| Dec 31, 2025 | -118.58% |
| Sep 30, 2025 | 8.27% |
| Jun 30, 2025 | 7.56% |
| Mar 31, 2025 | 23.97% |
| Dec 31, 2024 | -216.73% |
| Sep 30, 2024 | 33.68% |
| Jun 30, 2024 | 31.13% |
| Mar 31, 2024 | 29.74% |
| Sep 30, 2023 | 66.28% |
| Jun 30, 2023 | 75.87% |
| Mar 31, 2023 | 80.90% |
| Dec 31, 2022 | -14.94% |
| Sep 30, 2022 | 45.75% |
| Jun 30, 2022 | 45.65% |
| Mar 31, 2022 | 46.50% |
| Sep 30, 2021 | 55.21% |
| Jun 30, 2021 | 53.29% |
| Mar 31, 2021 | 53.02% |
| Dec 31, 2020 | 64.60% |